Anticipated Recommendation to Downgrade Ecstasy Raises Concerns
The Advisory Council on the Misuse of Drugs is expected to propose the reclassification of Ecstasy (MDMA). At present, ecstasy is categorized as a Class A drug, alongside heroin and cocaine. The recommendation to downgrade the drug to Class B appears to be based on a principle of “relative harm.” Such reclassification may be seen as both radical and constructive, enabling drug workers, as well as the wider criminal justice system to take more appropriate action. However, early indications...
